Pfizer announces 6000 job losses

The announcement follows Pfizer's acquisition of its rival company Wyeth in 2009. The cuts would take effect over the coming 18 months, with about 6,000 jobs expected to go worldwide.Eight plants in Ireland, Puerto Rico, and the United States are expected to close by the end of 2015, as well as about 90 jobs from the pharmaceutical plant in Hampshire, although the company said the vaccine packaging and distribution plant in Havant, which employs about 400 people, would remain open....................& more

A step closer to "Aids Vaccine"

Research findings published in Nature, may help international efforts to design an effective Aids vaccine. It seems some people have a natural protection against HIV, but the research team at MIT and Harvard says any such vaccine is at least a decade away.The findings relate to so-called "elite controllers" - a small number of people who, when exposed to HIV, progress very slowly to Aids or never deal all. In the late 1990s it was discovered that these individuals - about one in 200 of those infected with HIV - carry a specific gene, known as HLA B57.....................& more

Sanofi prostate cancer drug shows 28 percent survival

Sanofi-Aventis' cabazitaxel candidate prostate cancer drug combined with prednisone reduced the risk of death by 28 percent compared with another treatment, the outcome of a final-stage trial showed.The French drugmaker said on Thursday that the combination of the treatments led to an improved median overall survival of 15.1 months against 12.7 months in patients who took a chemotherapy of mitoxantrone with prednisone/prednisolone.The primary endpoint of the so-called Tropic trial was overall survival......................& more

Clinical Research

India is becoming a hub for clinical research; the demand for professionals in this field is growing rapidly. Clinical research business in India will be worth $1 billion by 2010. Thus, there will soon be a massive demand for clinical research professionals, making it an interesting career option with massive growth potential.
Clinical research is all set to become the next big thing in India. A large population with a substantial workforce and cost benefits influence multinationals to set up research facilities here. Besides due to the prevalence of a large variety of diseases, including widespread cases of cancer and diabetes India is viewed the world over as the ideal location for clinical research trials for the pharmaceutical industry.

Jazz Pharmaceuticals Submits New Drug Application For JZP-6 (sodium Oxybate) For The Treatment Of Fibromyalgia

Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for JZP-6 (sodium oxybate oral solution) for the treatment of fibromyalgia.

The submission is based on a comprehensive clinical development program for JZP-6, including results from two Phase III clinical trials. In both trials, sodium oxybate significantly decreased pain and fatigue as well as improved daily function, patient global impression of change, and sleep quality. Sodium oxybate has not been evaluated by regulators for the treatment of fibromyalgia and is not approved for this use....................&MORE

FDA Seeking to Fill Mission-Critical Positions

  • FDA are actively recruiting for mission-critical medical and science positions to strengthen our public health mission.
  • FDA are attending job fairs throughout the United States to promote available positions and recruit applicants.

Vertex Hepatitis C Drug Shows 75 Percent Cure Rate

Hepatitis C is one of the hottest areas for drug development and Vertex Pharmaceuticals has released a study that gives new hope to patients and investors. The results show its Telaprevir treatment increased the cure rate to 75 percent in a pivotal tiral of previously untreated patients, while also reducing the time needed for treatment. By contrast, the cure rate for patients who received only existing therapies was just 44 percent. Of those who got 12 weeks of telaprevir, 75 percent had a sustained viral response, meaning the virus was not detectable in their blood 24 weeks after completing treatment. That is seen as essentially a cure. The rate was 69 percent for those who got eight weeks of telaprevir...........&more

Safety and quality of raw medicinal plants

India has 16 agroclimatic zones, 45,000 different plant species and 15,000 medicinal plants. The Indian Systems of Medicine have identified 1,500 medicinal plants, of which 500 species are mostly used in the preparation of drugs. The medicinal plants contribute to cater 80 per cent of the raw materials used in the preparation of drugs. The effectiveness of these drugs mainly depend upon the proper use and sustained availability of genuine raw materials.

Endangered medicinal plants

The wild types of the popular medicinal plant ginseng (Panax ginseng), used to address digestive conditions resulting from nervous disorders, is currently reported to be rapidly declining due to increasing demand and collection...................& more

FDA approvals make big difference in Indian pharmaceutical sector

The US Food and Drug Administration (US FDA) approvals have made a huge impact on Indian drug sector. And over the years, with the Indian companies going out, it has become even more important.

The same can be seen by looking at the two developments that happened today. While Aurobindo Pharma managed to get a positive nod from the US regulator for its chicken pox drug, Valacyclovir Hydrochloride tablets; on the other hand Sun Pharmaceutical Industries' saw its profit go down for the 2010 financial year...................& more

Clintrac Clinical Research

Clintrac is a Contract Research Organization (CRO) with core strength in Bioavailability and Bioequivalence (BA/BE), Studies including pharmacokinetics (PK) study & Phase trials (Phase II - IV). Clintrac is committed to Quality Clinical Research and is located in the premises of 1000-bedded super speciality Vydehi Institute of Medical Sciences and Research Center (VIMS &RC), Whitefield, Bengaluru (Bangalore), India.
it provides Services in Medical writing, Regulatory Affairs,Clinical trial management (Phase II –IV), Bioavailability / Bioequivalence services including PK Studies, Clinical Data Management,Biostatis Quality Assurance
for vacancies at Clintrac Clinical here

Bristol-Myers Squibb pharma

Bristol-Myers Squibb is a global BioPharma company firmly focused on its Mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.Around the world, our medicines help millions of people in their fight against cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis and psychiatric disorders.
for vacancies at Bristol-Myers here

Bioserve research labs

bioserve provides world-class clinical research services to sponsors across the globe by Providing services that exceed the sponsor requirements of quality, compliance, time and cost. Committed compliance to regulatory and ethical Standards. Ensuring the safety, dignity and well-being of all study participants.
for vacancies at bioserve research here

Astra Zeneca Foundation, Bangalore

Astra Zeneca India Pvt. Limited (AZIPL) is an integral part of the global organisation with a mandate to discover new chemical entities for the treatment of infectious diseases of the developing world. The Company, with its state-of-the-art facility in Bangalore, is dedicated to the “ Discovery of Novel Therapies for the Developing World diseases”, an unique and brave commitment from one of the world’s leading pharmaceutical companies in the world, a recognition of the talent in India and the environment at Bangalore, a pledge to work together to combat diseases of the developing world like Tuberculosis, which needs a major research thrust to find newer therapies. The R&D facility in India has >90 scientists of international repute working together as a team, contributing effectively to the goal of discovering new and novel therapeutic agents.
For vacancies at Astra Zeneca Foundation here

Max Neeman A Leading CRO in INDIA

Max Neeman – A leading Contract Research Organization (CRO) based out of India provides full range of clinical research services to global pharmaceutical, biotech and devices companies. Based out of 6 regional offices, Max Neeman has access to hospitals and health care facilities across India. Operational since 2001, Max Neeman has been awarded 175 trials for global sponsors across wide range of   therapeutic areas.

Carrer with MAX  Neeman  Click here

Mouth Ulcer

-Papaya is good fruit to eat when you have mouth ulcers. It soothes the mouth ulcers and helps in their fast recovery.

Jubilant Clinsys

 Clinsys Clinical Research, Inc.® is a full-service clinical research organization (CRO) that provides pharmaceutical, biotechnology and medical device companies with a broad range of clinical research services in support of Phase I-IV drug and device development, including project management, clinical monitoring, scientific and medical support, investigator and patient recruitment, site management, biostatistics, data management, drug safety, quality assurance, regulatory affairs, and medical writing.
 FOR VACANCIES AT Jubilant Clinsys ..........Click here

CRO complete list in INDIA

Reliance Clinical Research labs
Bioserve Clinicals
GSK Clinicals

Hospira pharmaceutical and medication delivery company

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company that is focused on products that improve the safety, cost and productivity of patient care. Hospira is a leader in the development, manufacture and marketing of specialty injectable pharmaceuticals and medication delivery systems that deliver drugs and intravenous ("I.V.") fluids.
FOR VACANCIES AT Hospira..........Click here

Fulford Mumbai

Fulford is becoming a new kind of health care company -- dynamic, fast-forward and built on earning trust, every day. We believe that having the right people in the right jobs is critical to advancing our Action Agenda and becoming a high-performance competitor for the long term.
For vacancies at Fulford Mumbai here

Intas Pharmaceuticals Ltd.

Experience spanning three decades in healthcare industry, with a wide range of formulations to meet the needs of ailing humanity, Intas Pharmaceuticals, headquartered at Ahmedabad (India), is now a force to reckon with in the global pharma horizon.
With expertise in the range of formulations, from Tablets to Injectables to Newer Drug Delivery systems, Intas is currently ranked 16th amongst the Indian Pharma majors. A variety of initiatives in Research and Development (R & D), Patents and ANDA filing, NDDS, Quality manufacturing support, along with approvals from regulatory authorities of many countries has made Intas a global healthcare provider.
 FOR VACANCIES AT Intas Pharmaceuticals Ltd...........Click here

Emcure, Pune

Emcure was born out of the vision to create a healthcare company that would address the vast healthcare needs. Our commitment and drive have propelled our growth from a single manufacturing facility during the genesis, to a range of world class manufacturing facilities spread across API, formulations and biotechnology.Emcure is building its pipeline of Chiral and conventional APIs and is emerging as a strong  player in the biotechnology front.
for vacancies at Emcure Pune here

Dr Reddy's Laboratories Limited

As a fully integrated pharmaceutical company, our purpose is to provide affordable and innovative medicines through our three core businesses:Pharmaceutical Services and Active Ingredients, comprising our Active Pharmaceuticals and Custom Pharmaceuticals businesses;Global Generics, which includes branded and unbranded generics; and Proprietary Products, which includes New Chemical Entities (NCEs), Differentiated Formulations, and Generic Biopharmaceuticals.
ClinTec International for vacancies at Dr Reddy's Laboratories Limited here

Aurigene Discovery Technologies

Aurigene is a Small Molecule and Peptide Drug Discovery Partnership Company engaged in early stage discovery collaboration from Target to IND. Aurigene has 15 discovery programs with 9 collaborators world wide. Aurigene also provides specialized services in crystallography, peptides and small molecules including scale-up and ADME assays.
for vacancies at Aurigene Discovery Technologies here

Bayer healthcare pharmaseuticals

Bayer HealthCare Pharmaceuticals' goal is to discover products that will improve human health worldwide by diagnosing, preventing and treating diseases. As a specialty pharmaceutical company, we focus our efforts where we can have the most impact.
for vacancies in  Bayer HealthCare here

ClinTec International

ClinTec's clinical research services cover a broad spectrum of activities from protocol development and site identification/evaluation through to delivery of the final clinical study report.Whether you are looking for us to take over your complete project, provide individual outsourced services or simply insource our staff to your trial, we can guarantee you a cost effective solution that will meet, if not exceed, your timelines.With ClinTec you can be assured of high quality service and results that are delivered on time and within budget.
 for vacancies at ClinTec International here

Veeda Clinical Research

Veeda Clinical Research®  is a full service global CRO specializing in the early clinical development of drugs. With state-of-the-art facilities in the UK, India and Belgium, we provide a full range of services in phase I and IIa clinical research, delivering expert, cost effective research solutions to the Pharmaceutical and Biotechnology Industries worldwide.
for vacancies at Veeda Clinical here.

Dr. Reddys Lab launches hypertension drug in U.S.

Pharma major Dr. Reddys Laboratories on Monday said it has begun the sale of Amlodipine Benazepril capsules, used for the treatment of hypertension, in the U.SThe company launched the Amlodipine Benazepril capsules, which are a bio-equivalent generic version of Lotrel capsules, in the U.S. market on April 23, Dr. Reddy’s Laboratories said in a filing to the Bombay Stock Exchange (BSE).

The United States Food & Drug Administration granted approval for capsules on April 15, it said.“In September 2009, Dr. Reddy’s Laboratories had entered into a patent settlement with Novartis on Amlodipine Benazepril, stipulating the dismissal of the lawsuits in the U.S,” it added.